BZAM Ltd. (BZAMF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
BZAM Ltd. (BZAMF) trades at $0.00 with AI Score 49/100 (Grade C). BZAM Ltd. is a Canadian cannabis producer focused on branded consumer goods, operating facilities and retail stores across multiple provinces. Market cap: $2,708, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for BZAMF: BZAMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BZAMF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BZAMF: the 1 perspectives are evenly split.
How is this calculated? →BZAM Ltd. (BZAMF) Healthcare & Pipeline Overview
BZAM Ltd., formerly The Green Organic Dutchman, is a Canadian cannabis producer focused on branded consumer goods, operating facilities and retail stores across multiple provinces. With a portfolio of brands like BZAM and Highly Dutch Organic, the company caters to diverse consumer preferences in the evolving cannabis market, facing challenges in a competitive landscape.
What Is the Investment Thesis for BZAMF?
Investing in BZAM Ltd. presents a high-risk, high-reward scenario. The company operates in the volatile cannabis industry, characterized by evolving regulations and intense competition. BZAM's negative profit margin of -71.9% and a negative P/E ratio highlight the financial challenges it faces. The company's gross margin stands at 13.7%. Growth catalysts include potential expansion into new markets and the introduction of innovative products. However, investors should carefully consider the risks associated with investing in a company with negative profitability and significant competition.
Based on FMP financials and quantitative analysis
BZAMF Key Highlights
- BZAM Ltd. operates as a cannabis producer with a focus on branded consumer goods.
- The company's brands include BZAM, TGOD, ness, Highly Dutch Organic, and TABLE TOP.
- BZAM operates facilities in British Columbia, Alberta, Ontario, and Quebec.
- The company has retail stores in Winnipeg, Manitoba and Regina, Saskatchewan.
- BZAM's profit margin is -71.9%.
Who Are BZAMF's Competitors?
BZAMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BZAMF's Key Strengths?
- Diverse brand portfolio
- Strategic facility locations
- Retail network in key provinces
- Partnerships with established brands
What Are BZAMF's Weaknesses?
- Negative profit margin
- Intense competition
- Evolving regulatory landscape
- Limited brand recognition compared to larger players
What Could Drive BZAMF Stock Higher?
- Potential expansion into new Canadian provinces, increasing market reach.
- Continued development and launch of new cannabis products under existing and partner brands.
- Efforts to optimize production costs and improve gross margins.
What Are the Key Risks for BZAMF?
- Financial-distress signal — its Altman Z-Score of -6.12 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-23.0%) — the business is not currently generating profit on shareholder capital.
- Regulatory changes in the Canadian cannabis industry impacting production, distribution, and marketing.
- Intense competition from other cannabis producers, potentially leading to price wars and reduced profitability.
- Fluctuations in consumer demand and preferences for cannabis products.
- Difficulty in securing financing for expansion and operations.
What Are the Growth Opportunities for BZAMF?
- Expansion into New Product Categories: BZAM Ltd. has the opportunity to expand its product offerings beyond its current portfolio of cannabis brands. This could involve introducing new product formats, such as edibles, concentrates, or topicals, to cater to evolving consumer preferences. The market for cannabis edibles, for example, is projected to reach $4.1 billion in North America by 2026. By diversifying its product line, BZAM can attract new customers and increase its revenue streams.
- Geographic Expansion within Canada: BZAM can expand its retail footprint and distribution network within Canada. While the company already has facilities and retail stores in several provinces, there are opportunities to enter new markets, particularly in provinces with high cannabis consumption rates. Expanding into new regions would allow BZAM to reach a broader customer base and increase its overall market share. This expansion could be achieved through strategic partnerships, acquisitions, or organic growth.
- Strategic Partnerships and Collaborations: BZAM can pursue strategic partnerships and collaborations with other companies in the cannabis industry. This could involve partnering with established brands to distribute their products through BZAM's retail network or collaborating with research institutions to develop innovative cannabis products. Such partnerships can provide BZAM with access to new markets, technologies, and expertise, enhancing its competitive position.
- Focus on Organic and Sustainable Practices: BZAM can differentiate itself by emphasizing organic and sustainable cultivation practices. As consumer awareness of environmental issues grows, there is increasing demand for cannabis products that are produced in an environmentally responsible manner. By highlighting its commitment to sustainability, BZAM can attract environmentally conscious consumers and enhance its brand image. The company already has the 'Highly Dutch Organic' brand, which it can further leverage.
- Development of Proprietary Cannabis Strains: BZAM can invest in the development of proprietary cannabis strains with unique characteristics and effects. This would allow the company to differentiate its products from those of its competitors and create a loyal customer base. Developing proprietary strains requires significant investment in research and development, but it can provide BZAM with a sustainable competitive advantage. These strains can be trademarked and marketed as exclusive offerings.
What Opportunities Does BZAMF Have?
- Expansion into new product categories
- Geographic expansion within Canada
- Strategic partnerships and collaborations
- Focus on organic and sustainable practices
What Threats Does BZAMF Face?
- Changing consumer preferences
- Increased competition from new entrants
- Regulatory changes and compliance costs
- Economic downturn affecting consumer spending
What Are BZAMF's Competitive Advantages?
- Brand portfolio: A diverse portfolio of cannabis brands caters to different consumer segments.
- Production facilities: Strategically located facilities across Canada enable efficient production and distribution.
- Retail network: Company-owned retail stores provide direct access to consumers.
- Partnerships: Collaborations with other brands expand product offerings and market reach.
What Does BZAMF Do?
BZAM Ltd., headquartered in Vancouver, Canada, is a cannabis producer focused on branded consumer goods. Originally incorporated in 2016 as The Green Organic Dutchman Holdings Ltd., the company rebranded to BZAM Ltd. in February 2023. BZAM operates facilities across British Columbia, Alberta, Ontario, and Quebec, along with retail locations in Winnipeg, Manitoba, and Regina, Saskatchewan. The company's brand portfolio includes BZAM, TGOD, ness, Highly Dutch Organic, and TABLE TOP, as well as partner brands like Dunn Cannabis, FRESH, and Wyld. BZAM's operations span the cannabis value chain, from cultivation and processing to retail distribution. The company aims to cater to a broad range of consumer preferences within the cannabis market through its diverse brand offerings. BZAM faces competition from other established cannabis producers in Canada. The company's success depends on its ability to effectively manage production costs, maintain product quality, and adapt to evolving consumer preferences and regulatory changes within the cannabis industry.
What Products and Services Does BZAMF Offer?
- Cultivates and processes cannabis in facilities across multiple Canadian provinces.
- Manufactures and distributes branded cannabis products, including dried flower, oils, and edibles.
- Operates retail cannabis stores in Manitoba and Saskatchewan.
- Manages a portfolio of cannabis brands, including BZAM, TGOD, ness, and Highly Dutch Organic.
- Partners with other cannabis brands to distribute their products.
- Focuses on producing high-quality cannabis products for recreational and medical use.
How Does BZAMF Make Money?
- Cultivation and processing of cannabis.
- Manufacturing and distribution of branded cannabis products.
- Retail sales through company-owned stores.
- Wholesale distribution to other retailers.
What Industry Does BZAMF Operate In?
The Canadian cannabis industry is characterized by rapid growth, evolving regulations, and intense competition. Companies like BZAM operate in a landscape shaped by shifting consumer preferences and regulatory changes. The market includes both established players and emerging companies vying for market share. BZAM's focus on branded consumer goods positions it within the premium segment of the market. The industry is subject to ongoing regulatory developments related to production, distribution, and marketing, which can impact companies' operations and profitability.
Who Are BZAMF's Key Customers?
- Recreational cannabis consumers.
- Medical cannabis patients.
- Wholesale retailers.
- Strategic partners.
Company Profile
BZAM Ltd. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Matt Milich. BZAMF has traded publicly since 2018.
F-Score 4/9Financial Health
BZAM Ltd.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -6.12 places it in the distress zone, a signal of elevated financial risk.
ROE -23%Key Financial Metrics
Return on equity for BZAM Ltd. stands at -23.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -12.9%, showing how much profit it generates from its asset base. A current ratio of 2.08 indicates the company holds enough short-term assets to cover its near-term obligations.
BZAMF Valuation & Market Position
With a 3K market cap, BZAM Ltd. sits in the micro-cap segment of the market. Relative to its peer group, BZAMF's quantitative score of 49/100 is below the peer average of 66/100.
BZAMF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diverse brand portfolio
- Strategic facility locations
- Retail network in key provinces
- Partnerships with established brands
Bear Case
- Negative profit margin
- Intense competition
- Evolving regulatory landscape
- Limited brand recognition compared to larger players
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
BZAMF Latest News
No recent news available for BZAMF.
BZAMF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BZAMF.
Price Targets
Wall Street price target analysis for BZAMF.
BZAMF MoonshotScore
What does this score mean?
The MoonshotScore rates BZAMF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Matt Milich
CEO
Matt Milich serves as the CEO of BZAM Ltd. His background includes experience in the cannabis industry, with a focus on operations and strategic development. He has been involved in various aspects of the cannabis business, including cultivation, processing, and retail. Milich's expertise lies in driving growth and efficiency within cannabis organizations.
Track Record: Since becoming CEO, Matt Milich has focused on streamlining BZAM's operations and expanding its brand portfolio. Key initiatives include optimizing production processes and increasing distribution channels. Milich has also emphasized the importance of product quality and customer satisfaction. The company rebranded from The Green Organic Dutchman to BZAM Ltd. under his leadership.
BZAMF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that BZAMF may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and may have a higher risk profile.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Lower trading volume and liquidity
- Wider bid-ask spreads
- Higher price volatility
- Potential for fraud or manipulation
- Verify the company's registration and licensing status.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's products and services.
- Evaluate the competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established operations in multiple Canadian provinces.
- Portfolio of branded cannabis products.
- Retail presence in Manitoba and Saskatchewan.
- Experienced management team.
- Rebranding from The Green Organic Dutchman to BZAM Ltd.
Common Questions About BZAMF (Healthcare)
What does BZAM Ltd. do?
BZAM Ltd. is a Canadian cannabis producer focused on branded consumer goods. The company cultivates and processes cannabis in facilities across British Columbia, Alberta, Ontario, and Quebec. BZAM manufactures and distributes a range of cannabis products, including dried flower, oils, and edibles, under brands such as BZAM, TGOD, ness, and Highly Dutch Organic. The company also operates retail cannabis stores in Manitoba and Saskatchewan, providing direct access to consumers. BZAM aims to cater to diverse consumer preferences within the cannabis market through its varied brand offerings.
What do analysts say about BZAMF stock?
As of March 16, 2026, there is no readily available analyst consensus on BZAMF stock. The company's negative profit margin and P/E ratio suggest financial challenges. Investors should conduct thorough due diligence and consider the risks associated with investing in a volatile industry. Key valuation metrics and growth considerations should be carefully evaluated before making any investment decisions. The company's ability to improve profitability and expand its market share will be critical factors in its long-term success.
What are the main risks for BZAMF?
BZAMF faces several risks inherent to the cannabis industry. Regulatory changes in Canada could impact production, distribution, and marketing. Intense competition from other cannabis producers may lead to price wars and reduced profitability. Fluctuations in consumer demand and preferences for cannabis products could affect sales. The company also faces the risk of difficulty in securing financing for expansion and operations. As an OTC stock, BZAMF carries additional risks related to limited financial disclosure and lower liquidity.
What are the key factors to evaluate for BZAMF?
BZAM Ltd. (BZAMF) holds an AI score of 49/100 (low). Not financial advice.
How frequently does BZAMF data refresh on this page?
BZAMF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BZAMF's recent stock price performance?
BZAM Ltd. (BZAMF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse brand portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BZAMF overvalued or undervalued right now?
Valuing BZAM Ltd. (BZAMF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BZAMF?
Before investing in BZAM Ltd. (BZAMF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information.
- OTC analysis is based on general characteristics of the OTC market.